Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Preferred Shares (2016 - 2025)

Palisade Bio has reported Preferred Shares over the past 10 years, most recently at $2000.0 for Q4 2025.

  • Quarterly Preferred Shares changed 0.0% to $2000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $2000.0 for FY2025, 0.0% changed from the prior year.
  • Preferred Shares was $2000.0 for Q4 2025 at Palisade Bio, roughly flat from $2000.0 in the prior quarter.
  • Over five years, Preferred Shares peaked at $2000.0 in Q1 2021 and troughed at $2000.0 in Q1 2021.
  • The 5-year median for Preferred Shares is $2000.0 (2021), against an average of $2000.0.
  • The largest YoY upside for Preferred Shares was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
  • A 5-year view of Preferred Shares shows it stood at $2000.0 in 2021, then changed by 0.0% to $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Preferred Shares are $2000.0 (Q4 2025), $2000.0 (Q3 2025), and $2000.0 (Q2 2025).